A Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)

Clinical trial NCT06941844 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06941844
Sponsor: Definium Therapeutics US, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2025-04-14
Primary completion: 2026-05-20
Enrollment: 149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.